Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501338 · ClinicalTrials.gov registry record · NA
Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT07501338: Clinical Trial NA study, sponsored by Stanford University.
NCT07501338 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07501338, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.
Interventions
- DEVICE Tandem Automated Insulin Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2026-03 |
| Est. Completion | 2031-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07501338
The ClinicalTrials.gov registry entry for NCT07501338 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tandem Automated Insulin Delivery System is the first listed.
NCT07501338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07501338 about?
NCT07501338 is a clinical study titled "Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D". Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools f...
What is the current status of trial NCT07501338?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2026-03. Estimated completion is 2031-03.
What interventions are being tested in trial NCT07501338?
The interventions under investigation include: Tandem Automated Insulin Delivery System (DEVICE).
Who is sponsoring clinical trial NCT07501338?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.